Suzhou Basecare Enters Assisted Reproduction Cooperation Contract

MT Newswires Live
2024/12/24

Suzhou Basecare Medical (HKG:2170) entered into a strategic cooperation agreement with Shanghai Jinghua Medical Management for five years, a Tuesday bourse filing said.

Under the contract, the firm will provide Shanghai Jinghua Medical Management with AI-based solutions covering areas such as andrology testing, embryo culture, cryopreservation, and complex genetic diseases, with an aim to establish a world-class benchmark center for assisted reproduction.

The genetic technology research company will sell products and provide consulting services to Shanghai Jinghua Medical Management. Both parties will also collaborate on creating an intelligent reproductive genetics center.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10